Q1 EPS Forecast for DENTSPLY SIRONA Reduced by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of DENTSPLY SIRONA in a report released on Thursday, March 20th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will earn $0.31 per share for the quarter, down from their previous estimate of $0.42. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.81 EPS, Q1 2026 earnings at $0.34 EPS, Q2 2026 earnings at $0.48 EPS, Q3 2026 earnings at $0.49 EPS, Q4 2026 earnings at $0.58 EPS, FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.19 EPS.

Other equities research analysts also recently issued research reports about the stock. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho dropped their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. UBS Group dropped their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Finally, StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Stock Down 1.5 %

XRAY stock opened at $15.57 on Monday. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a 1-year low of $14.78 and a 1-year high of $33.42. The firm has a fifty day moving average price of $17.86 and a two-hundred day moving average price of $20.40. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.52% of the stock is owned by corporate insiders.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Treasurer of the State of North Carolina grew its position in DENTSPLY SIRONA by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock worth $1,686,000 after buying an additional 560 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the last quarter. MML Investors Services LLC raised its position in shares of DENTSPLY SIRONA by 2.1% during the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 620 shares during the period. Blue Trust Inc. boosted its position in shares of DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock valued at $137,000 after purchasing an additional 707 shares during the period. Finally, Quarry LP increased its stake in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.